ACAD
$19.12-2.99%
ACADIA Pharmaceuticals Inc.Stock · HealthcareRussell 2000 0.1%Nasdaq Composite 0.009%Russell 3000 0.005%US Stock Market 0.004%
ACAD — ACADIA Pharmaceuticals Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeEEEE
15.020.025.030.035.040.045.050.055.0020.0M40.0M$19.12—20162019202120242026
2026-10-16
Price$19.12
MA20$24.44
MA50$24.12
Vol9.9M
Key stats#
Price data
- Price
- $19.12
- YTD price return
- -28.42%
- YTD total return
- -28.42%
- Next earnings
- Nov 4, 2026
- Market cap
- 3.3B
- Enterprise value
- 3B
- Shares outstanding
- 172.3M
- 52W low
- $18.39
- 52W high
- $30.96
- From 52W high
- -38.24%
- From 52W low
- +3.97%
- 52W range
- 6%
Volume
- Rel volume
- 0.77×
- 30D volume
- 2.2M
- 30D $ vol
- 48.8M
Fundamentals
- Sales (ttm)
- 1.1B
- Sales/share
- $6.61
- EPS (ttm)
- $2.21
- FCF (ttm)
- 145.6M
- FCF/share
- $0.85
- Book value/share
- $7.58
- Net margin
- 33.42%
- ROE
- 29.12%
- ROA
- 21.83%
- Current ratio
- 3.39
Growth (CAGR, ttm) · 10Y
- Sales
- +11.76%+27.37%+19.70%+143.28%
- Net income
- +71.33%n/an/an/a
- FCF
- -22.17%n/an/an/a
- Shares
- +2.13%+1.72%+1.41%+4.22%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +66.63%n/an/an/a
- Sales/share
- +9.43%+25.23%+18.04%+133.43%
- FCF/share
- -23.80%n/an/an/a
- Book value/share
- +55.61%+46.37%+16.62%+7.78%
- Price
- -7.28%-7.01%+1.77%-2.11%
- Total return
- -7.28%-7.01%+1.77%-2.11%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 8.6×
- Fwd P/E
- 22.4×
- P/S (ttm)
- 2.9×
- P/B (mrq)
- 2.5×
- P/FCF (ttm)
- 22.6×
- EV/EBITDA (fy)
- 30.3×
- EV/Sales (ttm)
- 2.6×
- FCF yield (ttm)
- 4.42%
- Buyback yield (realized, 1y)
- -2.13%
- Shareholder yield (realized, 1y)
- -2.13%
- Buyback yield (cash, ttm)
- -1.42%
- Shareholder yield (cash, ttm)
- -1.42%
Vs own 10Y history
- P/S
- 3rd
- P/B
- 0th
Bar = where today’s multiple sits in ACAD’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-16#
1D
-2.99%
5D
-3.34%
1M
-30.57%
3M
-25.40%
YTD
-28.42%
1Y
-7.27%
5Y
+9.19%
Financial statements
Open full ACAD financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +10.48% | +0.43% |
| JNJ | Johnson & Johnson | -4.38% | +0.90% |
| ABBV | AbbVie Inc. | +8.73% | +0.71% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +6.97% | -1.29% |
| MRK | Merck & Co. Inc. | +0.72% | +0.52% |
| NVS | Novartis AG | +8.59% | +0.16% |
| TMO | Thermo Fisher Scientific Inc. | +6.41% | -0.93% |
| AMGN | Amgen Inc. | +14.92% | -0.35% |
